Anti-Human TL1A/TNFSF15 Reference Antibody|抗人TL1A/TNFSF15参考抗体(靶标：人TL1A（TNFSF15）)
- 货号：RB9THF526016
- 价格：面议
- 点击：348
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Human |
| 克隆性 | Monoclonal |
| 抗体亚型 | IgG1-kappa |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 浓度 | 4mg/ml |
| 内毒素水平 | Please contact the lab for this information. |
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 种属反应性 | Human |
| 靶标 | TNFSF15, Vascular endothelial cell growth inhibitor, VEGI, TL1, TNF ligand-related molecule 1, Tumor necrosis factor ligand superfamily member 15 |
| 储存缓冲液 | 0.01M PBS, pH 7.4. |
| 稳定性和储存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| 表达系统 | Mammalian Cells |
| 登录号 | O95150 |
| 背景信息 | Duvakitug is a humanized IgG1-λ2 monoclonal antibody targeting to TNFSF15/TL1A. Duvakitug' main expression system is CHOK1SV cells endogenously expressing glutamine synthetase (GS). Duvakitug can be used in the study of Crohn's Disease (CD). • Vascular endothelial growth inhibitor in human cancer (Review)., PMID:19513527 • VEGI-192, a new isoform of TNFSF15, specifically eliminates tumor vascular endothelial cells and suppresses tumor growth., PMID:16061878 |
| 别名 | 2648504-55-4 |
| 备注 | For research use only. Not suitable for clinical or therapeutic use. |
相关产品:
| 产品名称 | 点击数 |
|---|---|
| 倍硫磷单抗 | 6231 |
| 多菌灵/阿苯达唑二合一单抗 | 6270 |
| 三氯噻嗪单抗 | 6373 |
| 吡唑醚菌酯单抗 | 6573 |
| 烯酰吗啉单抗 | 6359 |
| 抑霉唑单抗 | 6118 |
| 恶醚唑（苯醚甲环唑）单抗 | 6304 |
| 赛拉嗪（甲苯噻嗪）单抗 | 6336 |
| 辛硫磷单抗 | 6378 |
| 多效唑单抗 | 6228 |
| 对硫磷单抗 | 6472 |
| 丙溴磷单抗 | 6462 |
| 戊唑醇单抗 | 6453 |
| 莠去津单抗 | 6378 |
| 灭蝇胺单抗 | 6076 |
| 尼卡巴嗪代谢物（DNC）单抗 | 6356 |
| 2.4-二氯苯氧乙酸单抗 | 6221 |
| 甲基对硫磷单抗 | 6310 |
| 左旋咪唑单抗 | 6229 |
| 三唑磷单抗 | 6288 |